Synapse - Heiko Schoder

Results (147)

Allogeneic hematopoietic cell transplantation impacts on immune evasive mechanisms in relapsed/refractory diffuse large B‐cell lymphoma – A single center experience

Meeting Abstract

Sauter, C. S.; Lin, R. J.; Ho, C.; Devlin, S. M.; Maloy, M. A.; Perales, M.; Dahi, P. B.; Schoder, H.; Jakubowski, A. A.; Barker, J. N.; more...
Hematological Oncology (2019)

Fulltext@MSK | Save

EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer

Journal Article

Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
Cancer Discovery (2019)

Fulltext@MSK | Save

Initial results of a phase II study of sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance for untreated mantle cell lymphoma

Meeting Abstract

Kumar, A.; Zelenetz, A. D.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P. A.; Laraque, L.; more...
Blood (2018)

Fulltext@MSK | Save

Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma

Meeting Abstract

Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase III multi-center, prospective randomized trial comparing high dose single fraction radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic human cancer

Meeting Abstract

Zelefsky, M. J.; Yamada, Y.; Lis, E.; Schoder, H.; Lochansingh, S.; Shi, W.; Zhigang, Z.; Braunstein, S. E.; Kolesnick, R.; Fuks, Z.
International Journal of Radiation Oncology, Biology, Physics (2018)

Fulltext@MSK | Save

Response to the letter to the editor by CM den Bakker and DL van Der Peet

Journal Article

Coit, D. G.; Hernandez, J.; Schoder, H.; Goldman, D.
Annals of Surgery (2018)

Fulltext@MSK | Save

A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL

Journal Article

Sauter, C. S.; Matasar, M. J.; Schoder, H.; Devlin, S. M.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; more...
Blood (2018)

Fulltext@MSK | Save

Uptake of [(18)F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma

Journal Article

Qi, S.; Huang, M. Y.; Yang, Y.; Schöder, H.; Teckie, S.; Noy, A.; Chau, K.; Yahalom, J.
Blood Advances (2018)

Fulltext@MSK | Save

Post-treatment/pre-operative PET response is not an independent predictor of outcomes for patients with gastric and GEJ adenocarcinoma

Journal Article

Hernandez, J. M.; Beylergil, V.; Goldman, D. A.; van Beek, E.; Gonen, M.; Tang, L.; Downey, R.; Rizk, N.; Shah, M.; Strong, V.; more...
Annals of Surgery (2018)

Fulltext@MSK | Save

A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC)

Meeting Abstract

Riaz, N.; Sherman, E. J.; Katabi, N.; Leeman, J. E.; Higginson, D. S.; Boyle, J.; Singh, B.; Morris, L. G.; Wong, R. J.; Tsai, C. J.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save